The Grow with Google Digital Coaches program has expanded to Houston. Photo via Unsplash

A new Google initiative is expanding its Texas presence this month. The Grow with Google's Digital Coaches program, which has already launched in Austin, has expanded to the Bayou City — making the Lone Star State the only state to have two locations of this entrepreneur-centric tool.

The program aims to provide digital skills training and coaching to Black and LatinX small business owners and create economic opportunity. Houston is one of eight new cities the program has recently expanded into.

"Houston has a vibrant and growing Black and LatinX small business community," says Lucy Pinto, Google's Digital Coach program manager, in a news release. "The Digital Coaches program will provide business owners in these communities with ongoing workshops and hands-on coaching sessions focused on techniques and digital tools to reach new customers, thrive online and grow."

Houston entrepreneur Joy M. Hutton, founder of Joy of Consulting, will serve as the Grow with Google Digital Coach for Houston. Hutton also runs a restaurant-focused consulting business called The Restaurant Girl and founded go GLAM, a beauty on demand platform.

"The Grow with Google team is making an effort to close the gap in resources that Black and LatinX small business owners have not generally had access to — in Houston and beyond," Hutton says in the release. "I live and breathe entrepreneurship, so I'm honored to participate in the Google Digital Coaches program and excited to work with Houston entrepreneurs who are traditionally underrepresented."

Joy M. Hutton will lead Grow with Google in Houston. Photo courtesy

According to the release, the program is expanding with inclusion in mind. This year, the program will grow to 20 mentors.

"As the representative of Houston's 18th District, a diverse and historic district, I know firsthand the importance and positive impact that investing in diverse communities and their residents can have on the entire population," says Rep. Sheila Jackson Lee in the release. "As Houston continues to prosper and grow, it is critical that we continue to invest in our minority-owned and small businesses to ensure an even brighter economic future for our city."

The program's first free workshop is called Connect with Customers and Manage Your Business Remotely and will be held virtually tomorrow, Friday, November 20, at 5:30 p.m. Moving forward, Grow with Google workshops will be hosted by Hutton on a regular basis, including the following sessions:

    • Dec. 3 at 5 p.m. CDT - Get Your Local Business on Google Search and Maps
    • Dec. 10 at 5 p.m. CDT - Reach Customers Online with Google
    • Dec. 17 at 5 p.m. CDT - Digital Skills for Everyday Tasks

    Both Google as well as local leadership are excited for the opportunities this program will provide Houstonians.

    "As a 'majority-minority' city that is the fourth-largest in the U.S., it is critical that our Black and LatinX business owners have the tools and knowledge to reach new customers, grow their businesses and help continue to make Houston a prosperous, skilled and inclusive city," Mayor Sylvester Turner says in the release. "The city of Houston is appreciative for the opportunity to provide invaluable resources and opportunities to our city's Black and LatinX small business owners."

    Ad Placement 300x100
    Ad Placement 300x600

    CultureMap Emails are Awesome

    Houston researchers report promising first in-human trial for implantable cancer therapy

    cancer breakthrough

    When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

    Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

    “Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

    Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

    If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

    The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

    “This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

    The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”

    Houston startup raises $6M to scale home-based healthcare platform

    fresh funding

    As healthcare systems race to expand care beyond hospitals and into the home, investors are placing bigger bets on the infrastructure needed to make that shift possible.

    This month, Rosarium Health announced it has raised $6 million in seed funding led by Kalos Ventures, with participation from ResilienceVC, Rock Health Capital, Symphonic Capital, Black Tech Nations Ventures and others.

    The investment will help the Houston-based startup continue to build its platform, which features a national network of 800-plus clinicians and 3,000-plus contractors to coordinate home accessibility upgrades and modifications for seniors and people living with disabilities.

    For founder and CEO Cameron Carter, the company’s mission grew out of firsthand caregiving experiences.

    “From my own personal caregiving experiences, I realized that the benefits exist on paper, but not in reality,” Carter said in a news release. “Families are being left to figure out the paperwork and installations all on their own, which shouldn’t be how this works.”

    While Medicare Advantage and Medicaid plans have expanded coverage for home-based services and accessibility modifications, the logistics behind delivering those services often remain fragmented.

    Rosarium’s platform coordinates the entire process, from clinical assessments and referrals to contractor management, documentation, reimbursement and installation.

    “A clinician can document that a home isn’t safe and a plan can approve a benefit, but there’s no one that’s responsible for making sure the work actually gets done,” Carter says. “We built the missing piece.”

    The company was founded in 2021 as Rose Health and was a 2023 participant in the Texas Medical Center’s Accelerator for HealthTech program. It has scaled quickly, building a network of more than 800 clinicians and 3,000 contractors across 34 states.

    Rosarium is currently in-network for 1.2 million Medicare and Medicaid lives, with projected coverage expected to reach nearly 4 million by the end of the year, according to the release.

    “We’re excited to back Cameron because he and the team at Rosarium are building the infrastructure healthcare needs right now to make the home a safe and comfortable place of care,” Kate Ballinger, investor at Kalos Ventures, added in the release.

    As part of the recent investment, Ballinger will join Rosarium’s board of directors.

    With eyes on the future, Rosarium plans to grow its partnerships with Medicaid and Medicare Advantage plans, including CalViva and Community Health Plan of Imperial Valley, strengthening its presence in California while expanding access to underserved communities.

    Additionally, Carter predicts that home-based healthcare will be part of a broader transformation happening across the industry.

    “There’s a growing recognition that health outcomes are shaped by what happens in the home,” he said in the release. “The future of healthcare isn’t just treating people after something goes wrong. It’s creating environments that help prevent those problems in the first place.”